Purchase Order 75N93020P00953
Award Date
7/27/20
Potential Completion Date
7/23/21
Potential Value
$12K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the COBAS AMPLIPREP/COBAS TAQMAN HIV-1 TEST V2. The $24,108.00 fixed-price contract was awarded on July 19, 2018 by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, and has a completion date of August 19, 2018. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The award is a delivery order under Roche's General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The award provides Roche's COBAS AMPLIPREP/COBAS TAQMAN HIV-1 Test Version 2, a viral load...
This federal contract award, valued at $82,450.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments, to provide COBAS kits to be used as HIV reagents in the NIAID Laboratory of Immunoregulation (LIR). The contract will be...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $38,800.00 firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The award is for 8 COBAS kits to be used as HIV reagents in the NIAID's Laboratory of Immunoregulation (LIR) and delivered in multiple shipments by June 30, 2025. This award was not set aside for any specific business type. Roche Diagnostics is a foreign-owned, for-profit...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of HIV assay kits. The potential value of the award is $21,697.20, with a completion date of November 30, 2017. This award was not set aside for any specific business type. Roche Diagnostics is a foreign-owned, for-profit...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation for the delivery of HIV assay kits. The contract has a ceiling value of $24,108.00 and an ultimate completion date of August 1, 2017. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,705.16 firm fixed price purchase order to Roche Diagnostics Corporation. The contract is for a standing order of COBAS 58/68/8800 HIV 192T in vitro diagnostic kits to be delivered to a location in Castleton, Indiana. No major subcontractors or set aside designations were indicated. This contract supports NIH/NIAID's efforts to conduct research on...
This contract award to Roche Diagnostics Corporation (Roche) is for the COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0. The contract, which has a ceiling value of $109,459.97, was awarded by the U.S. Army Medical Command (MEDCOM) for the delivery of this diagnostic test and is a firm fixed price Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation. Roche is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
The U.S. Defense Health Agency awarded a firm-fixed-price delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide a cost per test for the testing of Human Immunodeficiency Virus (HIV) for a base year plus one option year. The total potential value of the award is $183,235.04. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures and distributes in vitro diagnostics, reagents, laboratory instruments, and associated products...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $22,902.60, was awarded to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for "DRUGS AND BIOLOGICALS" and has a...